StockData
Braveheart Bio, Inc. logo

Braveheart Bio, Inc. (BRVE) stock

BRVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$18.53−0.25 (-1.33%)

Close on Nov 18, 2026Market cap $1.67BP/E –Yield –

Braveheart Bio shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Braveheart Bio's shares outstanding was 52M at Sep 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202652M–
Q2 FY2026Jun 30, 20267M–
Q3 FY2025Sep 30, 20256M–
Q2 FY2025Jun 30, 20253M–

More Braveheart Bio figures

See a number that looks wrong?